Skip to content
2000
Volume 22, Issue 1
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Abstract: Lung adenocarcinoma (LUAD) is the common histological subtype of non-small-cell lung carcinoma (NSCLC). Circular RNAs (circRNAs) represent a new class of non-coding RNAs (ncRNAs) involved in the development of cancer. Accumulating evidence indicated that a large number of circular RNAs were found to be involved in many biological processes, including tumor initiation, proliferation and progression. These circRNAs present great potentials as new biomarkers and vital targets for disease diagnosis and prognosis. In this review, we mainly focus on the differentially expressed circRNAs and their functions in the pathogenesis of LUAD, which makes it possible for the utility of circRNAs as novel biomarkers for early diagnosis and therapy. Especially, it is helpful to develop circRNAs as crucial therapeutic targets, thus providing a promising biomedical application in the field of cancer gene therapy.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523221666211202095258
2022-02-01
2025-05-23
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523221666211202095258
Loading

  • Article Type:
    Review Article
Keyword(s): application; biomarker; Circular RNA; diagnosis; lung adenocarcinoma; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test